Oppenheimer Asset Management Inc. Purchases Shares of 58,929 Bath & Body Works, Inc. $BBWI

Oppenheimer Asset Management Inc. bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 58,929 shares of the company’s stock, valued at approximately $1,363,000.

Several other institutional investors have also recently bought and sold shares of BBWI. Parallel Advisors LLC boosted its holdings in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the last quarter. State of Michigan Retirement System raised its position in Bath & Body Works by 1.2% in the first quarter. State of Michigan Retirement System now owns 49,300 shares of the company’s stock worth $920,000 after acquiring an additional 600 shares during the period. Meeder Asset Management Inc. boosted its stake in Bath & Body Works by 28.5% in the fourth quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock valued at $58,000 after acquiring an additional 637 shares during the last quarter. State of Wyoming increased its stake in shares of Bath & Body Works by 6.2% during the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after purchasing an additional 661 shares during the last quarter. Finally, Vident Advisory LLC raised its holdings in shares of Bath & Body Works by 2.8% in the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after purchasing an additional 692 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

NYSE:BBWI opened at $19.40 on Monday. The firm has a market capitalization of $3.91 billion, a P/E ratio of 5.45, a PEG ratio of 1.92 and a beta of 1.38. The company’s fifty day moving average price is $20.37 and its 200-day moving average price is $20.16. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $32.32.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm’s revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities analysts anticipate that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 4.1%. Bath & Body Works’s payout ratio is presently 22.47%.

Analyst Ratings Changes

BBWI has been the topic of a number of recent analyst reports. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 9th. TD Cowen raised their price target on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Wells Fargo & Company raised their target price on shares of Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a research note on Tuesday, June 23rd. Finally, Jefferies Financial Group upped their target price on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $21.93.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.